GAMIFANT Trademark

Trademark Overview


On Thursday, December 29, 2016, a trademark application was filed for GAMIFANT with the United States Patent and Trademark Office. The USPTO has given the GAMIFANT trademark a serial number of 87283834. The federal status of this trademark filing is REGISTERED as of Tuesday, July 3, 2018. This trademark is owned by NovImmune SA. The GAMIFANT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral...

Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes
gamifant

General Information


Serial Number87283834
Word MarkGAMIFANT
Filing DateThursday, December 29, 2016
Status700 - REGISTERED
Status DateTuesday, July 3, 2018
Registration Number5505933
Registration DateTuesday, July 3, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes
Goods and ServicesBiochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSWEDISH ORPHAN BIOVITRUM AG
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPLAN-LES-OUATES, GENEVA 1228
CH

Party NameEMACO SA
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGENEVA
CH

Party NameNovImmune SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGeneva 1228
CH

Party NameNovImmune SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGeneva 1228
CH

Party NameNovImmune SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGeneva 1228
CH

Trademark Events


Event DateEvent Description
Wednesday, October 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 18, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, July 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 20, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 20, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 20, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 25, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 17, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 2, 2017NON-FINAL ACTION E-MAILED
Thursday, November 2, 2017NON-FINAL ACTION WRITTEN
Thursday, October 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2017ASSIGNED TO LIE
Wednesday, September 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION WRITTEN
Monday, March 27, 2017ASSIGNED TO EXAMINER
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 2, 2017NEW APPLICATION ENTERED